Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00 | 300.00 | 500.00 | 700.00 | 900.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.00K | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.60K | 4.60K | 4.60K | -- | -- |
| Total Current Assets | 39.60K | 4.90K | 5.10K | 700.00 | 900.00 |
|
|
|||||
| Total Current Assets | 39.60K | 4.90K | 5.10K | 700.00 | 900.00 |
| Net Property, Plant & Equipment | 13.70K | 20.30K | 26.90K | 33.40K | 39.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 4.60K | 4.60K |
| Total Assets | 53.30K | 25.20K | 32.00K | 38.70K | 45.30K |
|
|
|||||
| Total Accounts Payable | 95.50K | 143.20K | 154.50K | 155.50K | 152.70K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 241.70K | 147.90K | 125.60K | 115.30K | 109.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.70K | 18.00K | 26.90K | 26.50K | 26.10K |
| Total Finance Division Other Current Liabilities | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Current Liabilities | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Current Liabilities | 370.80K | 329.10K | 326.90K | 317.30K | 308.00K |
|
|
|||||
| Total Current Liabilities | 370.80K | 329.10K | 326.90K | 317.30K | 308.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 241.70K | 147.90K | 125.60K | 115.30K | 109.20K |
| Capital Leases | -- | -- | -- | 6.90K | 13.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 370.80K | 329.10K | 326.90K | 324.20K | 321.70K |
|
|
|||||
| Common Stock & APIC | 32.37M | 32.36M | 32.36M | 32.36M | 32.36M |
| Retained Earnings | -32.68M | -32.67M | -32.66M | -32.65M | -32.64M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -317.50K | -303.90K | -295.00K | -285.50K | -276.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -317.50K | -303.90K | -295.00K | -285.50K | -276.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -317.50K | -303.90K | -295.00K | -285.50K | -276.40K |
|
|
|||||